Latest Breaking News On - Esperion corporate communications - Page 1 : comparemela.com

Esperion Therapeutics (ESPR) Enters Co-Promotion Agreement With Currax Pharmaceuticals

Esperion Therapeutics (ESPR) Enters Co-Promotion Agreement With Currax Pharmaceuticals
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sheldon koenigGeorge hamptonEsperion corporate communicationsCurrax pharmaceuticalsExchange commissionChief executive officerPrescribing information

Esperion Announces Co-Promotion Agreement With Currax Pharmaceuticals LLC

– Performance-Based Agreement Provides for Currax’s 72 Sales Representatives to Detail Esperion’s Products – – Reinforces Esperion’s Focus on Driving. | April 19, 2023

George hamptonSheldon koenigEsperion corporate communicationsExchange commissionMore than doubling sales teamCurrax pharmaceuticalsPerformance based agreement providesDetail esperionReinforces esperionDriving persistent growthChief executive officerPrescribing informationEsperion therapeuticsNc stock exchangePress releaseN espr us29664w1053

Esperion Therapeutics (ESPR) Prices 33 17M Share Offering at $1 675/sh

Esperion Therapeutics (ESPR) Prices 33 17M Share Offering at $1 675/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesExchange commissionHc wainwright coEsperion corporate communications

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomMphil cantabKausik raySheldon koenigExchange commissionProfessor of public healthEuropean atherosclerosis societyWorld congressHonorary cardiologist at imperial college londonEsperion corporate communicationsBempedoic acidComplete statin intoleranceLipid managementUsing bempedoic acidAtherosclerotic cardiovascular disease

Esperion Therapeutics (ESPR) Reports CLEAR Outcomes Study Demonstrates NEXLETOL Tablet is the Only LDL-C Lowering Therapy

Esperion Therapeutics (ESPR) Reports CLEAR Outcomes Study Demonstrates NEXLETOL Tablet is the Only LDL-C Lowering Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joanne foodyEsperion therapeuticsatSheldon koenigExchange commissionEsperion therapeutics incWorld congressEsperion corporate communicationsWall streetCholesterol loweringInhibiting regimenAmerican collegeAnnual scientific sessionNew england journalOutcomes trialTendon rupturePrescribing information